Download PDF
Exp Clin Endocrinol Diabetes 2007; 115(1): 7-12
DOI: 10.1055/s-2007-949150
Article

© J. A. Barth Verlag in Georg Thieme Verlag KG · Stuttgart · New York

A Novel Non-Synonymous Mutation in the Melanocortin-4 Receptor Gene (MC4R) in a 2-Year-Old Austrian Girl with Extreme Obesity

E. Rettenbacher 1 , P. Tarnow 3 , H. Brumm 3 , D. Prayer 4 , A. -K. Wermter 5 , J. Hebebrand 1 , H. Biebermann 3 , A. Hinney 1 , K. Widhalm 2
  • 1Department of Child and Adolescent Psychiatry, Rheinische Kliniken Essen, University of Duisburg-Essen, Germany
  • 2Division of Nutrition and Metabolism, Department of Paediatrics, Medical University of Vienna, Austria
  • 3Paediatric Endocrinology, Charité Children's Hospital, Humboldt University of Berlin, Germany
  • 4Department of Radiology, Division of Neuroradiology, Medical University of Vienna, Austria
  • 5Department of Child and Adolescent Psychiatry, Philipps-University of Marburg, Germany
Further Information

Publication History

Received 29.4.2006 First decision 13.6.2006

Accepted 7.7.2006

Publication Date:
07 February 2007 (online)

Also available at
    Permissions and Reprints

Abstract

Background: Functionally relevant mutations in the melanocortin-4 receptor gene (MC4R) currently display the most common major gene/allele effect on extreme obesity.

Objective: Mutation screen of the MC4R in consecutively ascertained Austrian children and adolescents with severe obesity, to analyse the phenotype of mutation carriers and to functionally characterise novel mutations.

Subjects and Methods: 102 unrelated extremely obese children and adolescents (mean BMI 33.5±7.1 kg/m2, >97th centile; mean age 13.8±4.1 yr) and 109 parents (79 mothers/30 fathers) of 88 of these patients were studied. The MC4R coding region was screened using denaturing high-performance liquid chromatography (dHPLC); PCR products of aberrant dHPLC pattern were re-sequenced. Signal transduction properties of mutant MC4R was investigated by challenge with the highly potent agonist NDP-α-MSH. Cell surface expression was determined by ELISA. Magnetic resonance imaging (MRI) of the central nervous system (CNS) was applied to a 2.3 year old index patient. Body fat and bone mineral content were assessed in three of the five mutation carriers by dual energy x-ray absorptiometry (DEXA). Oral glucose tolerance test (OGTT) was applied to some mutation carriers.

Results: Heterozygous carriers of two non-synonymous mutations, two polymorphisms and a silent variation were identified within the study group. (1) A novel MC4R non-synonymous mutation (S136F) was detected in a 2.3 year old girl with extreme obesity (BMI 33.2 kg/m2, >99th centile); (2) a previously described non-synonymous mutation (V253I) was identified in an obese mother (BMI 28.1 kg/m2) who did not transmit this mutation to her extremely obese son; (3) two known polymorphisms (V103I and I251L) were also identified; and (4) one obese mother was carrier of a silent variation (c.594C>T; I198). Co-segregation of S136F with the obesity phenotype was shown for three generations. In vitro functional studies revealed a complete loss of signal transduction activity of the mutant receptor while cell surface expression was only slightly reduced compared to the wild-type receptor.

Conclusions: We detected a novel non-synonymous mutation (S136F) that leads to a complete loss of MC4R function in vitro.

Key words

obesity - G proteins - signal transduction - obesity melanocortin receptors

References

  • 1 Archarya S, Karnik SS. Modulation of GDP release from transducin by the conserved Glu134-Arg135 sequence in rhodopsin.  J Biol Chem. 1996;  271 25406-25411
    CrossrefPubMedGoogle Scholar
  • 2 Biebermann H, Schoneberg T, Schulz A, Krause G, Gruters A, Schultz G, Gudermann T. A conserved tyrosine residue (Y601) in transmembrane domain 5 of the human thyrotropin receptor serves as a molecular switch to determine G-protein coupling.  FASEB J. 1998;  12 1461-1471
    PubMedGoogle Scholar
  • 3 Dempfle A, Hinney A, Heinzel-Gutenbrunner M, Raab M, Geller F, Gudermann T, Schäfer H, Hebebrand J. Large quantitative effect of melanocortin-4 receptor gene mutations on body mass index.  J Med Genet. 2004;  41 795-800
    CrossrefPubMedGoogle Scholar
  • 4 Dubern B, Clement K, Pelloux V, Froguel P, Girardet JP, Guy-Grand B, Tounian P. Mutational analysis of melanocortin-4 receptor, agouti-related protein, and α-melanocyte-stimulating hormone genes in severely obese children.  J Pediatr. 2001;  139 204-209
    PubMedGoogle Scholar
  • 5 Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome.  Nature. 1997;  385 165-168
    CrossrefPubMedGoogle Scholar
  • 6 Farooqi IS, Yeo GS, Keogh JM, Aminian S, Jebb SA, Butler G, Cheetham T, O'Rahilly S. Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency.  J Clin Invest. 2000;  106 271-279
    CrossrefPubMedGoogle Scholar
  • 7 Farooqi IS, Keogh JM, Yeo GS, Lank EJ, Cheetham T, O'Rahilly S. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene.  N Engl J Med. 2003;  348 1085-1095
    CrossrefPubMedGoogle Scholar
  • 8 Gantz I, Miwa H, Konda Y, Shimoto Y, Tashiro T, Watson SJ, Del Valle J, Yamada T. Molecular cloning, expression and gene lokalization of a fourth melanocortin receptor.  J Biol Chem. 1993;  268 15174-15179
    CrossrefPubMedGoogle Scholar
  • 9 Geller F, Reichwald K, Dempfle A, Illig T, Vollmert C, Herpertz S, Siffert W, Platzer M, Hess C, Gudermann T, Biebermann H, Wichmann HE, Schäfer H, Hinney A, Hebebrand J. Melanocortin-4 receptor gene variant I103 is negatively associated with obesity.  Am J Hum Genet. 2004;  74 572-581
    CrossrefPubMedGoogle Scholar
  • 10 Govaerts C, Srinivasan S, Shapiro A, Zhang S, Picard F, Clement K, Lubrano-Berthelier C, Vaisse C. Obesity-associated mutations in the melanocortin 4 receptor provide novel insights into its function.  Peptides. 2005;  26 1909-1919
    CrossrefPubMedGoogle Scholar
  • 11 Hebebrand J, Himmelmann GW, Heseker H, Schafer H, Remschmidt H. Use of percentiles for the body mass index in anorexia nervosa: diagnostic, epidemiological and therapeutic considerations.  Int J Eat Disord. 1996;  19 359-369
    CrossrefPubMedGoogle Scholar
  • 12 Heid IM, Vollmert C, Hinney A, Döring A, Geller F, Löwel H, Wichmann HE, Illig T, Hebebrand J, Kronenberg F. and the KORA group . Association of the 103I MC4R allele with decreased body mass in 7937 participants of two population-based surveys.  J Med Genet. 2005;  42 e21
    CrossrefPubMedGoogle Scholar
  • 13 Hinney A, Schmidt A, Nottebom K, Heibült O, Becker I, Ziegler A, Gerber G, Sina M, Görg T, Mayer H, Siegfried W, Fichter M, Remschmidt H, Hebebrand J. Several mutations in the melanocortin 4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans.  J Clin Endocrinol Metab. 1999;  84 1483-1486
    CrossrefPubMedGoogle Scholar
  • 14 Hinney A, Hohmann S, Geller F, Vogel S, Hess C, Wermter AK, Brokamp B, Goldschmidt H, Siegfried W, Remschmidt H, Schäfer H, Gudermann T, Hebebrand J. Melanocortin-4 receptor gene: case-control study and transmission disequilibrium test confirm that functionally relevant mutations are compatible with a major gene effect for extreme obesity.  J Clin Endocrinol Metab. 2003;  88 4258-4267
    CrossrefPubMedGoogle Scholar
  • 15 Hinney A, Bettecken T, Tarnow P, Brumm H, Reichwald K, Lichtner P, Scherag A, Nguyen TT, Schlumberger P, Rief W, Vollmert C, Illig T, Wichmann HE, Schafer H, Platzer M, Biebermann H, Meitinger T, Hebebrand J. Prevalence, spectrum and functional characterization of melanocortin-4 receptor gene mutations in a representative population-based sample and obese adults from Germany.  J Clin Endocrinol Metab. 2006;  21 , Epub ahead of print
    PubMedGoogle Scholar
  • 16 Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P, Lee F. Targeted disruption of the melanocortin-4 receptor results in obesity in mice.  Cell. 1997;  88 131-141
    CrossrefPubMedGoogle Scholar
  • 17 Jacobson P, Ukkola O, Rankinen T, Snyder EE, Leon AS, Rao DC, Skinner JS, Wilmore JH, Lönn L, Cowan GS, Jr, Sjöström L, Bouchard C. Melanocortin 4 Receptor Sequence Variations Are Seldom A Cause of Human Obesity: The Swedish Obese Subjects, the HERITAGE Familiy Study, and a Memphis Cohort.  J Clin Endocrinol Metab. 2002;  87 4442-4446
    CrossrefPubMedGoogle Scholar
  • 18 Kim MS, Rossi M, Abusnana S, Sunter D, Morgan DG, Small CJ, Edwards CM, Heath MM, Stanley SA, Seal LJ, Bhatti JR, Smith DM, Ghatei MA, Bloom SR. Hypothalamic localization of the feeding effect of agouti-related peptide and alpha-melanocyte-stimulating hormone.  Diabetes. 2000;  49 177-182
    PubMedGoogle Scholar
  • 19 King BM, Cook JT, Rossiter KN, Rollins BL. Obesity-inducing amygdala lesions: examination of anterograde degeneration and retrograde transport.  Am J Physiol Regul Integr Comp Physiol. 2003;  284 R965-982
    PubMedGoogle Scholar
  • 20 Kishi T, Aschkenasi CJ, Lee CE, Mountjoy KG, Saper CB, Elmquist JK. Expression of melanocortin 4 receptor mRNA in the central nervous system of the rat.  J Comp Neurol. 2003;  457 213-235
    CrossrefPubMedGoogle Scholar
  • 21 Kobayashi H, Ogawa Y, Shintani M, Ebihara K, Shimodahira M, Iwakura T, Hino M, Ishihara T, Ikekubo K, Kurahachi H, Nakao K. A novel homozygous missense mutation of melanocortin-4 receptor (MC4R) in a Japanese woman with severe obesity.  Diabetes. 2002;  51 243-246
    PubMedGoogle Scholar
  • 22 Kromeyer-Hauschild K, Wabitsch M, Kunze D. et al . Perzentile für den Bodymass-Index für das Kindes-und Jugendalter unter Heranziehung verschiedener deutscher Stichproben.  Monatsschrift Kinderheilkd. 2001;  149 807-818
    CrossrefPubMedGoogle Scholar
  • 23 Larsen LH, Echwald SM, Sorensen TI, Andersen T, Wulff PS, Pedersen O. Prevalence of mutations and functional analyses of melanocortin 4 receptor variants identified among 750 men with juvenile-onset obesity.  J Clin Endocrinol Metab. 2005;  90 219-224
    CrossrefPubMedGoogle Scholar
  • 24 Loscher W, Brandt C, Ebert U. Excessive weight gain in rats over extended kindling of the basolateral amygdale.  Neuroreport. 2003;  14 1829-1832
    CrossrefPubMedGoogle Scholar
  • 25 Lubrano-Berthelier C, Le Stunff C, Bougneres P, Vaisse C. A homozygous null mutation delineates the role of the melanocortin-4 receptor in humans.  J Clin Endocrinol Metab. 2004;  89 2028-2032
    CrossrefPubMedGoogle Scholar
  • 26 Manzoni P, Brambilla P, Pietrobelli A, Beccaria L, Bianchessi A, Mora S, Chiumello G. Influence of body composition on bone mineral content in children and adolescents.  Am J Clin Nutr. 1996;  64 603-607
    PubMedGoogle Scholar
  • 27 Marti A, Corbalán MS, Forga L, Martinez JA, Hinney A, Hebebrand J. A novel nonsense mutation in the melanocortin-4 receptor associated with obesity in a Spanish population.  Int J Obes Relat Metab Disord. 2003;  27 385-388
    CrossrefPubMedGoogle Scholar
  • 28 Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.  Diabetologia. 1985;  28 412-419
    Google Scholar
  • 29 Mergen M, Mergen H, Ozata M, Oner R, Oner C. A novel melanocortin 4 receptor (MC4R) gene mutation associated with morbid obesity.  J Clin Endocrinol Metab. 2001;  86 3448-3451
    CrossrefPubMedGoogle Scholar
  • 30 Miraglia del Giudice E, Cirillo G, Nigro V, Santoro N, D'Urso L, Raimondo P, Cozzolino D, Scafato D, Perrone L. Low frequency of melano-cortin-4 receptor (MC4R) mutations in a Mediterranean population with early-onset obesity.  Int J Obes Relat Metab Disord. 2002;  26 647-651
    CrossrefPubMedGoogle Scholar
  • 31 Mountjoy KG, Mortrud MT, Low MJ, Simerly RB, Cone RD. Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain.  Mol Endocrinol. 1994;  8 1298-1308
    CrossrefPubMedGoogle Scholar
  • 32 Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA, Le Trong I, Teller DC, Okada T, Stenkamp RE, Yamamoto M, Miyano M. Crystal structure of rhodopsin: A G protein-coupled receptor.  Science. 2000;  289 739-745
    CrossrefPubMedGoogle Scholar
  • 33 Rollins BL, King BM. Amygdala-lesion obesity: what is the role of the various amygdaloid nuclei?.  Am J Physiol Regul Integr Comp Physiol. 2000;  279 R1348-1356
    PubMedGoogle Scholar
  • 34 Salomon Y, Londos C, Rodbell M. A highly sensitve adenylate cyclase assay.  Anal Biochem. 1974;  58 541-548
    CrossrefPubMedGoogle Scholar
  • 35 Schulz A, Grosse R, Schultz G, Gudermann T, Schöneberg T. Structural implication for receptor oligomerization from functional reconstitution studies of mutant V2 vasopressin receptors.  J Biol Chem. 2000;  275 2381-2389
    CrossrefPubMedGoogle Scholar
  • 36 Tao YX, Segaloff DL. Functional analyses of melanocortin-4 receptor mutations identified from patients with binge eating disorder and nonobese or obese subjects.  J Clin Endocrinol Metab. 2005;  90 5632-5638
    CrossrefPubMedGoogle Scholar
  • 37 Tarnow P, Schoneberg T, Krude H, Gruters A, Biebermann H. Mutationally induced disulfide bond formation within the third extracellular loop causes melanocortin 4 receptor inactivation in patients with obesity.  J Biol Chem. 2003;  278 48666-48673
    CrossrefPubMedGoogle Scholar
  • 38 Vaisse C, Clement K, Guy-Grand D, Froguel P. A frameshift mutation in human MC4R is associated with a dominant form of obesity.  Nat Genet. 1998;  20 113-114
    CrossrefPubMedGoogle Scholar
  • 39 Vaisse C, Clement K, Durand E, Hercberg S, Guy-Grand B, Froguel P. Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity.  J Clin Invest. 2000;  106 253-262
    CrossrefPubMedGoogle Scholar
  • 40 Valli-Jaakola K, Lipsanen-Nyman M, Oksanen L, Hollenberg AN, Kontula K, Bjoerbaek C, Schalin-Jäntti C. Identification and characterization of melanocortin-4 receptor gene mutations in morbidly obese Finnish children and adults.  J Clin Endocrinol Metab. 2004;  89 940-945
    CrossrefPubMedGoogle Scholar
  • 41 Wiegand S, Maikowski U, Blankenstein O, Biebermann H, Tarnow P, Gruters A. Type 2 diabetes and impaired glucose tolerance in European children and adolescents with obesity-a problem that is no longer restricted to minority groups.  Eur J Endocrinol. 2004;  151 199-206
    CrossrefPubMedGoogle Scholar
  • 42 Yeo GS, Farooqi IS, Aminian S, Halsall DJ, Stanhope RG, O'Rahilly S. A frameshift mutation in MC4R associated with dominantly inherited human obesity.  Nat Genet. 1998;  20 111-112
    CrossrefPubMedGoogle Scholar
  • 43 Yeo GS, Lank EJ, Farooqi IS, Keogh J, Challis BG, O'Rahilly S. Mutations in the human melanocortin-4 receptor gene associated with severe familial obesity disrupts receptor function through multiple molecular mechanisms.  Hum Mol Genet. 2003;  12 561-574
    CrossrefPubMedGoogle Scholar
  • 44 Zakel UA, Wudy SA, Heinzel-Gutenbrunner M, Gorg T, Schafer H, Gortner L, Blum WF, Hebebrand J, Hinney A. Prevalence of melanocortin 4 receptor (MC4R) mutations and polymorphismsin consecutively ascertained obese children and adolescents from a pediatric health care utilization population.  Klin Padiatr. 2005;  217 244-249
    Article in Thieme ConnectPubMedGoogle Scholar

Correspondence

K. Widhalm

Währinger Gürtel 18-20

A - 1090 Wien

Email: kurt.widhalm@meduniwien.ac.at